Related Experiment Video
Updated: Sep 23, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
The influence of lipoic acid on adriamycin induced nephrotoxicity in rats
Kumaravel Palanichamy Malarkodi1, Andithangal Venkatesan Balachandar, Palaninathan Varalakshmi
1Department of Medical Biochemistry, Dr A.L.M. Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, India.
Abstract:
Adriamycin, which is widely used in the treatment of various neoplastic conditions, exerts toxic effects in several organs. Adriamycin nephrotoxicity has been recently documented in a variety of animal species. The present study was designed to investigate the effect of lipoic acid on the nephrotoxic potential of adriamycin. The study was carried out with adult male albino rats of Wistar strain. Test animals were divided into four groups of six rats each as follows: Group I (control) received only normal saline throughout the course of the experiment. Group II (ADR) received intravenous injections of adriamycin through the tail vein (1 mg kg(-1) body wt day(-1)) once a week for a period of 12 weeks. Group III (LA) received lipoic acid (35 mg kg(-1) body wt day(-1)) intraperitoneally once a week for a period of 12 weeks. Group IV (ADR + LA) received a single injection of lipoic acid intraperitoneally 24 h prior to the administration of adriamycin through the tail vein once a week for a period of 12 weeks. Intravenous injections of adriamycin resulted in decreased activities of the glycolytic enzymes; hexokinase, phosphoglucoisomerase, aldolase and lactate dehydrogenase in the rat renal tissue. The gluconeogenic enzymes, glucose-6-phosphatase and fructose-1,6-diphosphatase, showed a decline in their activities on adriamycin administration. The transmembrane enzymes namely the Na+,K+-ATPase, Ca2+-ATPase, Mg2+-ATPase and the brush-border enzyme alkaline phosphatase also showed a decrease in their activities. This decrease in the activities of ATPases and alkaline phosphatase suggests basolateral and brush-border membrane damage. Decreased activities of the TCA cycle enzymes isocitrate dehydrogenase, succinate dehydrogenase and malate dehydrogenase, suggest a loss in mitochondrial function and integrity. Nephrotoxicity was evident from the increased excretions of N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transferase in the urine of adriamycin administered rats. These biochemical disturbances were effectively counteracted on pre-treatment with lipoic acid, which brought about an increase in the activities of glycolytic enzymes, ATPases and the TCA cycle enzymes. On the other hand, the gluconeogenic enzymes showed a further decrease in their activities on lipoic acid pretreatment. LA pretreatment also restored the activities of the urinary enzymes to normal. These observations shed light on the nephroprotective action of lipoic acid rendered against experimental aminoglycoside toxicity.
Insights
Lipoic acid (LA) protects against Adriamycin (ADR)-induced nephrotoxicity by restoring kidney enzyme activities and reducing urinary damage markers. This study highlights lipoic acid
Area of Science:
- Biochemistry
- Nephrology
- Pharmacology
Background:
- Adriamycin (ADR) is a vital chemotherapeutic agent with known nephrotoxic side effects.
- Adriamycin-induced kidney damage is characterized by altered enzyme activities and increased urinary biomarkers.
- Lipoic acid (LA) is an antioxidant with potential protective properties.
Purpose of the Study:
- To investigate the protective effects of lipoic acid against Adriamycin-induced nephrotoxicity in a rat model.
- To evaluate the impact of lipoic acid on key renal enzyme activities and urinary damage indicators following Adriamycin administration.
Main Methods:
- Adult male Wistar rats were divided into four groups: control, Adriamycin (ADR) only, lipoic acid (LA) only, and ADR + LA.
- Adriamycin was administered intravenously weekly for 12 weeks; lipoic acid was administered intraperitoneally prior to Adriamycin.
- Activities of glycolytic, gluconeogenic, transmembrane, and TCA cycle enzymes were measured in renal tissue.
- Urinary excretion of N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transferase was assessed.
Main Results:
- Adriamycin administration significantly decreased glycolytic, transmembrane, and TCA cycle enzyme activities, indicating renal damage and mitochondrial dysfunction.
- Increased urinary excretion of N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transferase confirmed Adriamycin-induced nephrotoxicity.
- Lipoic acid pretreatment effectively counteracted these biochemical disturbances, restoring enzyme activities and normalizing urinary markers.
- Gluconeogenic enzyme activities further decreased with lipoic acid pretreatment.
Conclusions:
- Lipoic acid demonstrates significant nephroprotective effects against Adriamycin-induced kidney damage.
- LA pretreatment helps preserve renal mitochondrial function and membrane integrity by restoring key enzyme activities.
- These findings support the potential therapeutic role of lipoic acid in mitigating Adriamycin nephrotoxicity.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Toxicity: Risk factors
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
